secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xtant Medical Holdings, Inc. (XTNT)
CIK:        0001453593
Form:       8-K
Filed at:   2023-03-01T23:59:59+00:00
Accession:  0001493152-23-006396
Event type: m_and_a
Sentiment:  positive
Materiality: 0.80
Item codes: 1.01, 2.01, 2.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xtant Medical acquires Coflex product line from Surgalign for $17M cash
-----------------------------------------------------------------------

- Acquired Coflex and CoFix product lines from Surgalign for $17M cash; closed Feb 28, 2023.
- Coflex is only FDA PMA-approved interlaminar stabilization device for lumbar spinal stenosis; over 200,000 patients implanted.
- Expected to add ~$14M in annual revenue with attractive margins; helps Xtant achieve profitability.
- Funded with cash on hand and $5M additional borrowing under amended Term Credit Agreement (SOFR+7%, maturity May 2026).
- Acquisition expands Xtant's ASC/outpatient offering and adds new distributors and trained surgeons.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453593/000149315223006396/0001493152-23-006396-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453593/000149315223006396/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-006396

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer